The Royal Shakespeare Company (RSC) postpones its 2027 production of “Othello,” in which Sharon D. Clarke was set to play the title role. The change follows Clarke’s diagnosis of cancer and her decision to begin treatment, with the RSC saying the actor needs “time and space” to undergo care.
The production had been scheduled to run from 13 February to 3 April 2027 at the Swan Theatre in Stratford-upon-Avon. Several outlets report that the adaptation, directed by Monique Touko, reimagines Shakespeare’s tragedy through a lens of Black lesbian identity and related themes. Metro also notes the staging is set against a climate-threatened future. In other coverage, Clarke’s personal announcement about her diagnosis is foregrounded, alongside the impact on the performance schedule.
The RSC says affected ticket holders are automatically refunded and that a replacement programme will be announced. Across reports, the common focus is the same: the production’s timing changes to accommodate Clarke’s treatment while maintaining the company’s intention to return to the project later.
